From the USA: Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death

From the USA: Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death Liver grafts from hepatitis C virus-positive (HCV+) donation after circulatory death (DCD) donors have one-year patient and graft survival comparable with that of donation after brain death (DBD) liver grafts from donors with or without HCV infection, according to a study published […]

Broadcasting from Poland: High Insulin Levels Genetically Linked to Lower Lipoprotein(a)

Broadcasting from Poland: High Insulin Levels Genetically Linked to Lower Lipoprotein(a) There is an association between genetically predicted increased insulin concentrations and decreased concentrations of circulating lipoprotein(a) (Lp[a]), according to a study published online Aug. 29 in Cardiovascular Diabetology to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in […]

ESC Congress Study Highlights Safety of Aficamten in Hypertrophic Cardiomyopathy

ESC Congress Study Highlights Safety of Aficamten in Hypertrophic Cardiomyopathy At the European Society of Cardiology (ESC) Congress 2024, the cardiology community received its deepest insights yet into the potential of aficamten in the management of hypertrophic cardiomyopathy ahead of the anticipated Q3 submission to the US Food and Drug Administration, including an integrated safety analysis […]

Broadcasting from ESC 2024 – Siddharth Patel, MD, MPH: Abelacimab Could Help Reduce Procedure-Related Bleeding

Broadcasting from ESC 2024 – Siddharth Patel, MD, MPH: Abelacimab Could Help Reduce Procedure-Related Bleeding New data from the AZALEA-TIMI 71 trial is shedding further light on the potential benefits of factor XI inhibition with abelacimab. Presented at the European Society of Cardiology (ESC) Congress 2024, the analysis focused on periprocedural and procedural-related bleeding events, with […]

USA: Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men

USA: Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men The incidence rate of hepatitis C virus (HCV) reinfection was 4.7 per 100 person-years among men who have sex with men (MSM) with HIV who cleared HCV, according to a study published online July 18 in Clinical Infectious Diseases. Daniel S. Fierer, M.D., […]

From the USA: Variable Test Performance Seen With FIT for Advanced Colorectal Neoplasia

From the USA: Variable Test Performance Seen With FIT for Advanced Colorectal Neoplasia Fecal immunochemical tests (FITs) have variable sensitivity and specificity for detecting advanced colorectal neoplasia (ACN), according to a study published online Sept. 3 in the Annals of Internal Medicine. Barcey T. Levy, M.D., Ph.D., from the University of Iowa Carver College of Medicine […]

From ESC 2024 – EMPACT-MI Kidney: SGLT2 Initiation Can Preserve Kidney Function in Post-MI Population

From ESC 2024 – EMPACT-MI Kidney: SGLT2 Initiation Can Preserve Kidney Function in Post-MI Population An analysis of the EMPACT-MI study presented at the European Society of Cardiology (ESC) Congress 2024 underlines the safety of initiating SGLT2 inhibitor therapy in patients with a history of acute myocardial infarction. The analysis demonstrates use of the SGLT2 inhibitor empagliflozin […]

Reporting from ESC 2024 – PALISADE: Plozasiran Offers Hope for Treating Familial Chylomicronemia Syndrome

Reporting from ESC 2024 – PALISADE: Plozasiran Offers Hope for Treating Familial Chylomicronemia Syndrome New phase 3 data from plozasiran, a small interfering RNA therapy, presented at the European Society of Cardiology (ESC) Congress 2024 indicates there could be hope on the horizon for patients with familial chylomicronemia syndrome (FCS). The trial, named the PALISADE trial, found […]

Directly from ESC 2024 – Kausik Ray, MD, MPhil: INTERASPIRE and the Expanding Knowledge Base for Lipoprotein(a)

Directly from ESC 2024 – Kausik Ray, MD, MPhil: INTERASPIRE and the Expanding Knowledge Base for Lipoprotein(a) Few topics or biomarkers have garnered the same amount of attention for their association with cardiovascular risk in recent years as lipoprotein(a) [Lp(a)]. This trend continued at the European Society of Cardiology (ESC) Congress 2024, as the cardiology community and […]